Monopar Therapeutics
Earnings Surprise
Analysts estimated MNPR earnings of $-0.50 per share this quarter (Q4). MNPR's actual earnings were $-0.64 per share.
MNPR EPS surprise of -27.29%Analysts estimated MNPR earnings of $-0.44 per share this quarter (Q3). MNPR's actual earnings were $-0.48 per share.
MNPR EPS surprise of -9.44%Analysts estimated MNPR earnings of $-0.48 per share this quarter (Q2). MNPR's actual earnings were $-0.35 per share.
MNPR EPS surprise of 27.30%Analysts estimated MNPR earnings of $-0.69 per share this quarter (Q1). MNPR's actual earnings were $-0.38 per share.
MNPR EPS surprise of 45.21%Analysts estimated MNPR earnings of $-0.43 per share this quarter (Q4). MNPR's actual earnings were $-2.75 per share.
MNPR EPS surprise of -541.92%Analysts estimated MNPR earnings of $-0.49 per share this quarter (Q3). MNPR's actual earnings were $-0.37 per share.
MNPR EPS surprise of 23.90%Analysts estimated MNPR earnings of $-0.48 per share this quarter (Q2). MNPR's actual earnings were $-0.50 per share.
MNPR EPS surprise of -5.04%Analysts estimated MNPR earnings of $-0.12 per share this quarter (Q1). MNPR's actual earnings were $-0.10 per share.
MNPR EPS surprise of 18.30%Analysts estimated MNPR earnings of $-0.16 per share this quarter (Q4). MNPR's actual earnings were $-0.12 per share.
MNPR EPS surprise of 31.75%Analysts estimated MNPR earnings of $-0.17 per share this quarter (Q3). MNPR's actual earnings were $-0.14 per share.
MNPR EPS surprise of -19.26%